ADC Technology Market is expected to reach USD 15.82 Bn by 2030

The Global Antibody-Drug Conjugates ADC Technology Market, valued at USD 8.32 billion in 2023, is anticipated to reach USD 15.82 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.6%. This burgeoning market reflects the increasing adoption and innovation within ADC technology, particularly in its application for targeted cancer therapies.